Akcea Therapeutics, Inc.
(NASDAQ : AKCA)

( )
AKCA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc.
-2.14%93.512.1%$1060.68m
JNJJohnson & Johnson
1.14%122.830.6%$846.32m
PFEPfizer Inc.
0.52%36.490.9%$764.94m
MRKMerck & Co., Inc.
0.46%61.460.6%$632.61m
BMYBristol-Myers Squibb Company
2.28%55.171.4%$398.95m
LLYEli Lilly and Company
-0.21%85.891.0%$320.09m
NVSNovartis AG Sponsored ADR
1.47%75.070.2%$126.96m
SNYSanofi Sponsored ADR
2.40%39.970.2%$118.48m
AZNAstraZeneca PLC Sponsored ADR
-0.26%35.061.3%$98.27m
GSKGlaxoSmithKline plc Sponsored ADR
0.21%40.900.2%$82.61m
NVONovo Nordisk A/S Sponsored ADR Class B
0.97%46.850.1%$80.12m
LCILannett Company, Inc.
0.36%14.0537.9%$9.72m
AKTXAkari Therapeutics Plc Sponsored ADR
0.00%2.001.7%$0.14m
EPIXESSA Pharma Inc
-1.28%3.850.0%$0.07m

Company Profile

Akcea Therapeutics, Inc. is a late-stage pharmaceutical company, which engages in the development and commercializing of drugs fro the treatment of cardio metabolic diseases caused by lipid disorders. Its products include novel drugs under the followng brands: volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.